Schultes, US
Birgit Schultes, Arlington, MA US
Patent application number | Description | Published |
---|---|---|
20080206318 | Therapeutic compositions that alter the immune response - The invention is therapeutic methods and compositions that alter the immunogenicity of the host. | 08-28-2008 |
20080220012 | Therapeutic Compositions that alter the immune response - The invention is therapeutic methods and compositions that alter the immunogenicity of the host. | 09-11-2008 |
20120183976 | METHODS OF ASSESSING ACTIVITY OF A POLYSACCHARIDE COMPOSITION - Methods of assessing polysaccharide preparations lacking substantial anticoagulant activity are provided herein. | 07-19-2012 |
Birgit C. Schultes, Arlington, MA US
Patent application number | Description | Published |
---|---|---|
20080311127 | Combination therapy for treating disease - Disclosed are methods for treating cancer comprising administering a xenotypic antibody and a chemotherapeutic drug to a patient suffering from cancer. Also disclosed is a method for inducing a host immune response in a patient against a multi-epitopic in vivo tumor antigen present in the host serum, which antigen does not elicit an effective host immune response, comprising administering to the patient a chemotherapeutic drug and a composition comprising a binding agent that specifically binds to a first epitope on the antigen and allowing the binding agent to form a binding agent/antigen pair, wherein an effective host immune response is elicited against a second epitope on the antigen. | 12-18-2008 |
20090220493 | Reagents and methods for inducing an immune response to prostate specific antigen - The invention is an apparatus and method for the treatment of prostate cancer, and involves administering an antibody that specifically binds with prostate antigen. | 09-03-2009 |
20090291075 | BINDING AGENTS AND THEIR USE IN TARGETING TUMOR CELLS - The present invention concerns methods and compositions for administering a binding agent to a patient wherein the patient generates a response to autologous tumor. The binding agents target apoptotic tumor cells and facilitates the uptake of these apoptotic tumor cell are taken up by dendritic cells or other antigen presenting cells for processing and presentation to the immune system without the expression of circulating tumor-associated antigen (or without the need of circulating tumor antigen). | 11-26-2009 |
20110091466 | IgE ANTIBODIES FOR THE TREATMENT OF CANCER - The present invention provides monoclonal IgE antibodies comprising Fc epsilon (ε) constant regions and variable regions comprising at least one antigen binding region specific for binding a single epitope of a circulating, tumor-associated antigen (TAA) that is not a cell surface antigen wherein the epitope of the targeted antigen is not highly repetitive or is a non-repetitive epitope. The IgE antibodies of the invention are useful in the treatment of cancer associated with the tumor antigen. In one embodiment the TAA is prostate-specific antigen (PSA). | 04-21-2011 |
20110256124 | METHODS FOR IMPROVING THE BIOACTIVITY OF THERAPEUTIC IgE ANTIBODIES FOR THE TREATMENT OF DISEASE - The invention provides a method for increasing the bioactivity (e.g. the biosafety and efficacy) of a therapeutic IgE antibody of the invention in the treatment of a patient. Methods of the invention include: i) administering to the patient a therapeutic IgE antibody in combination with at least one bioactivity-enhancing agent, ii) strategic treatment regimens and protocols for the dosing and administration of a therapeutic IgE antibody of the invention, and iii) the use of a therapeutic IgE antibody having a variable region comprising at least one antigen binding region specific for binding an epitope of an antigen wherein the epitope is not highly repetitive or is non-repetitive. | 10-20-2011 |
20130022614 | IgE ANTIBODIES FOR THE TREATMENT OF CANCER - The present invention provides monoclonal IgE antibodies comprising Fc epsilon (ε) constant regions and variable regions comprising at least one antigen binding region specific for binding a single epitope of a circulating, tumor-associated antigen (TAA) that is not a cell surface antigen wherein the epitope of the targeted antigen is not highly repetitive or is a non-repetitive epitope. The IgE antibodies of the invention are useful in the treatment of cancer associated with the tumor antigen. In one embodiment the TAA is prostate-specific antigen (PSA). | 01-24-2013 |
20130058920 | METHODS FOR IMPROVING THE BIOACTIVITY OF THERAPEUTIC IgE ANTIBODIES FOR THE TREATMENT OF DISEASE - The invention provides a method for increasing the bioactivity (e.g. the biosafety and efficacy) of a therapeutic IgE antibody of the invention in the treatment of a patient. Methods of the invention include: i) administering to the patient a therapeutic IgE antibody in combination with at least one bioactivity-enhancing agent, ii) strategic treatment regimens and protocols for the dosing and administration of a therapeutic IgE antibody of the invention, and iii) the use of a therapeutic IgE antibody having a variable region comprising at least one antigen binding region specific for binding an epitope of an antigen wherein the epitope is not highly repetitive or is non-repetitive. | 03-07-2013 |
Connie Lee Schultes, Springdale, OH US
Patent application number | Description | Published |
---|---|---|
20140000086 | METHOD OF CONFORMING AN OVERWRAP TO A PESSARY DEVICE | 01-02-2014 |
Erik A. Schultes, Durham, NC US
Patent application number | Description | Published |
---|---|---|
20090087838 | ANALYTE DETECTION USING AUTOCATALYTIC CHAIN REACTIONS - Compositions and methods for detecting the presence of analytes employing autocatalytic chain reactions (ACR) having super linear kinetics for amplification of signal are disclosed. | 04-02-2009 |
Helen Ann Schultes, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20100122220 | Method of and apparatus for dynamically generating a user presentation based on database stored rules - A method of dynamically generating a user presentation includes selecting and retrieving at least one of a plurality of rules stored in one or more databases in response to a request from an application program, executing the rule to retrieve data from the one or more databases, and generating presentation data based on the data. The presentation data may be for use in the user presentation of the application program. | 05-13-2010 |
Joel A. Schultes, Corning, NY US
Patent application number | Description | Published |
---|---|---|
20120304695 | PRECISION GLASS ROLL FORMING PROCESS AND APPARATUS - A process and apparatus for precision glass roll forming a supply of molten glass at a glass temperature of 1000° C. or higher. A pair of hot forming rolls having a surface temperature of about 500° C. or higher, vertically below the glass feed, that thin the supplied stream of molten glass to produce a formed glass ribbon. A pair of cold sizing rolls maintained at a surface temperature of about 400° C. or lower, vertically below the forming rolls, that thin the formed glass ribbon glass to produce a sized glass ribbon having a desired thickness and a desired thickness uniformity. The sized glass ribbon may have a thickness of 1 mm or less that varies in thickness by no more than +/−0.025 mm. | 12-06-2012 |
Joel Andrew Schultes, Corning, NY US
Patent application number | Description | Published |
---|---|---|
20100050874 | Exhaust after treatment system and method - An exhaust after treatment system includes a wall-flow particulate filter and a flow-through substrate positioned upstream of the filter. The substrate has a plurality of channels defining a mean channel length, a first flow-through region including a first portion of the channels, and a second flow-through region including a second portion of the channels. The first flow-through region includes unplugged channels having lengths less than the mean channel length and the second flow-through region includes unplugged channels having lengths greater than the mean channel length. | 03-04-2010 |
20110121477 | Methods Of Operating An Extrusion Apparatus - Methods of operating an extrusion apparatus are provided for extruding ceramic or ceramic-forming material. The extrusion apparatus includes an extrusion die mounted with respect to a barrel. At least one screw is rotatably mounted within the barrel, and a feeder is configured to introduce a batch material to the screw. Example methods can adjust at least one of a rotational rate of the screw to an initial rotational rate or a feed rate of the feeder to an initial feed rate when based on a changed operating condition and/or when the batch material reaches the extrusion die. At least one of the rotational rate of the screw or the feed rate of the feeder can then be increased during a transient state until a steady state is reached. | 05-26-2011 |
Joel Andrew Schultes, Coming, NY US
Patent application number | Description | Published |
---|---|---|
20140151915 | EXTRUSION SYSTEMS AND METHODS WITH TEMPERATURE CONTROL - Extrusion systems and methods with temperature control are disclosed. The ceramic batch material is flowed through a front section wherein the temperature of the batch material is locally adjusted through its perimeter at multiple locations. The temperature-adjusted ceramic batch material is then extruded through the extrusion die to form the extrudate. Temperatures of the extrudate at multiple outer surface locations having different azimuthal positions are measured. The temperature adjustment of the ceramic batch material is then controlled in a first feedback loop to control the shape of the extrudate based on the measured outer surface temperatures. The front section can also be cooled using a second control loop. | 06-05-2014 |
Keyan Schultes, Corning, NY US
Patent application number | Description | Published |
---|---|---|
20100143215 | EXTRUDED BODY DEVICES AND METHODS FOR FLUID PROCESSING - Disclosed is a device for processing fluids, the device comprising an extruded body having multiple elongated cells therein, the body having a first fluidic passage therethrough defined principally within at least some of said cells, the first fluidic passage having a longitudinally serpentine path back and forth along the at least some of said cells. | 06-10-2010 |
Matthew Leonard Schultes, Carroll, IA US
Patent application number | Description | Published |
---|---|---|
20150329791 | Biodiesel Cold Filtration Process - An improved biodiesel production process includes the steps of processing a feedstock to produce biodiesel, cooling the biodiesel so as to form sediment, and filtering the biodiesel to remove the sediment. The resulting biodiesel from the cold filtration process avoids problems of sediment formation during storage and transportation. | 11-19-2015 |